These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25693591)

  • 21. Autoimmune/inflammatory syndrome leading to macrophage activation syndrome: An example of autoinflammatory spectrum disorder?
    Buda P; Gietka P; Wieteska-Klimczak A; Smorczewska-Kiljan A; Książyk J
    Isr Med Assoc J; 2016 Sep; 18(9):571. PubMed ID: 28681590
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoinflammatory conditions: when to suspect? How to treat?
    Grateau G; Duruöz MT
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):401-11. PubMed ID: 20534373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoinflammatory diseases: update on classification diagnosis and management.
    Pathak S; McDermott MF; Savic S
    J Clin Pathol; 2017 Jan; 70(1):1-8. PubMed ID: 27646526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammasome and cytokine blocking strategies in autoinflammatory disorders.
    Moll M; Kuemmerle-Deschner JB
    Clin Immunol; 2013 Jun; 147(3):242-75. PubMed ID: 23697917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy.
    Jéru I; Hentgen V; Normand S; Duquesnoy P; Cochet E; Delwail A; Grateau G; Marlin S; Amselem S; Lecron JC
    Arthritis Rheum; 2011 Jul; 63(7):2142-8. PubMed ID: 21480187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoinflammatory syndromes for the dermatologist.
    Dávila-Seijo P; Hernández-Martín A; Torrelo A
    Clin Dermatol; 2014; 32(4):488-501. PubMed ID: 25017460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders.
    Onel KB; Onel K
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1024-8. PubMed ID: 20506257
    [No Abstract]   [Full Text] [Related]  

  • 28. Alarming consequences - autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1.
    Holzinger D; Roth J
    Curr Opin Rheumatol; 2016 Sep; 28(5):550-9. PubMed ID: 27464597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review.
    Chang C
    J Autoimmun; 2013 Mar; 41():100-10. PubMed ID: 23375846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome.
    Wekell P; Karlsson A; Berg S; Fasth A
    Acta Paediatr; 2016 Oct; 105(10):1140-51. PubMed ID: 27426283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of autoinflammatory syndromes.
    Gattorno M; Martini A
    Curr Opin Pediatr; 2010 Dec; 22(6):771-8. PubMed ID: 20966753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-associated periodic syndrome in adults.
    Menon SG; Efthimiou P
    Rheumatol Int; 2018 Jan; 38(1):3-11. PubMed ID: 28942479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
    Cavalli G; Dinarello CA
    Rheumatology (Oxford); 2015 Dec; 54(12):2134-44. PubMed ID: 26209330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Danger signals and inflammasomes in autoinflammatory and autoimmune diseases].
    Bendtzen K
    Ugeskr Laeger; 2011 Sep; 173(38):2340-3. PubMed ID: 21936977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory Diseases.
    Ostrov BE; Amsterdam D
    Immunol Invest; 2021 Oct; 50(7):833-856. PubMed ID: 33941025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on Autoinflammatory Diseases: Interferonopathies.
    Davidson S; Steiner A; Harapas CR; Masters SL
    Curr Rheumatol Rep; 2018 May; 20(7):38. PubMed ID: 29846818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hereditary periodical fever syndromes].
    Herlin T; Sørensen N; Veirum J
    Ugeskr Laeger; 2011 Mar; 173(13):968-73. PubMed ID: 21453638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
    Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
    Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.